Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Blasczyk

Showing results (141-150 of 210) with videos related to

Pageof 21
Sort By:
Haematologica|October 12, 2010
The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic familyChristina Bade-Döding, Alex Theodossis, Stephanie Gras, et al.
International Journal of Molecular Sciences|January 26, 2019
Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer ImmunotherapyDamaris A Schillingmann, Sebastian B Riese, Vijith Vijayan, et al.
Plos One|December 23, 2015
Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell ActivationEva Zilian, Hendry Saragih, Vijith Vijayan, et al.
HLA|October 21, 2025
LMP2A-Targeting CAR-T Cells Equipped With Inducible IL-18 to Address EBV-Associated MalignanciesAnna Christina Dragon, Stefanie Thoelke, Philip Mausberg, et al.
Frontiers in Immunology|April 10, 2023
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximabSabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, et al.
Journal of Immunological Methods|June 1, 2014
Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approachesSabine Tischer, Daria Dieks, Cinja Sukdolak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2025
Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejectionAnna Christina Dragon, Agnes Bonifacius, Stefan Lienenklaus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2024
<i>In Vitro</i> Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMVMarkus Benedikt Krueger, Agnes Bonifacius, Anna Christina Dragon, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|January 19, 2026
Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different CarcinomasMelina Umland, Anna Christina Dragon, Luca Marie Beermann, et al.
Pharmaceutics|October 18, 2019
The Mechanistic Differences in HLA-Associated Carbamazepine HypersensitivityGwendolin S Simper, Lareen S Gräser, Alexander A Celik, et al.
Pageof 21

Showing results (141-150 of 210) with videos related to

Sort By:
Pageof 21
Haematologica|October 12, 2010
The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic familyChristina Bade-Döding, Alex Theodossis, Stephanie Gras, et al.
International Journal of Molecular Sciences|January 26, 2019
Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer ImmunotherapyDamaris A Schillingmann, Sebastian B Riese, Vijith Vijayan, et al.
Plos One|December 23, 2015
Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell ActivationEva Zilian, Hendry Saragih, Vijith Vijayan, et al.
HLA|October 21, 2025
LMP2A-Targeting CAR-T Cells Equipped With Inducible IL-18 to Address EBV-Associated MalignanciesAnna Christina Dragon, Stefanie Thoelke, Philip Mausberg, et al.
Frontiers in Immunology|April 10, 2023
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximabSabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, et al.
Journal of Immunological Methods|June 1, 2014
Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approachesSabine Tischer, Daria Dieks, Cinja Sukdolak, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2025
Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejectionAnna Christina Dragon, Agnes Bonifacius, Stefan Lienenklaus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2024
<i>In Vitro</i> Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMVMarkus Benedikt Krueger, Agnes Bonifacius, Anna Christina Dragon, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|January 19, 2026
Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different CarcinomasMelina Umland, Anna Christina Dragon, Luca Marie Beermann, et al.
Pharmaceutics|October 18, 2019
The Mechanistic Differences in HLA-Associated Carbamazepine HypersensitivityGwendolin S Simper, Lareen S Gräser, Alexander A Celik, et al.
Pageof 21